61.70

1.93% 1.17

Transmedics Group Inc (TMDX)

Overview News Price History Option Chain Financials Why TMDX Down? Discussions Forecast

Transmedics Group Inc stock is traded at $61.70, with a volume of 1.52M. It is up +1.93% in the last 24 hours and down -20.08% over the past month. TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Previous Close:

$60.53

Open:

$60

24h Volume:

1.52M

Relative Volume:

0.85

Market Cap:

$2.07B

Revenue:

$401.09M

Net Income/Loss:

$32.64M

P/E Ratio:

-56.09

EPS:

-1.1

Net Cash Flow:

$-120.51M

1W Performance:

-3.98%

1M Performance:

-20.08%

6M Performance:

-57.15%

1Y Performance:

-20.11%

1-Day Range:

$59.72

$62.50

1-Week Range:

$59.72

$66.44

52-Week Range:

$59.72

$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Name

Transmedics Group Inc

Sector

Healthcare (1176)

Industry

Medical Devices (148)

Phone

(978) 552-0900

Address

200 MINUTEMAN ROAD, ANDOVER, MA

Employee

584

Twitter

@transmedics

Next Earnings Date

2024-10-28

Latest SEC Filings

TMDX's Discussions on Twitter

Compare TMDX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMDX Transmedics Group Inc	61.70	2.07B	401.09M	32.64M	-120.51M	0.94
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Needham	Buy
Oct-29-24	Reiterated	Oppenheimer	Outperform
Sep-24-24	Initiated	Robert W. Baird	Outperform
Aug-21-24	Initiated	Needham	Buy
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight
Jun-04-24	Initiated	Stephens	Overweight
Mar-28-24	Initiated	Piper Sandler	Overweight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral
Apr-07-20	Initiated	Oppenheimer	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Morgan Stanley	Equal-Weight

View All

Transmedics Group Inc Stock (TMDX) Latest News

Dec 19, 2024

TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year LowHere's Why - MarketBeat

Dec 19, 2024

Dec 18, 2024

TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.4%Here's Why - MarketBeat

Dec 18, 2024

Geode Capital Management LLC Has $119.94 Million Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Dec 18, 2024

Dec 17, 2024

TransMedics Group (NASDAQ:TMDX) Receives "Neutral" Rating from JPMorgan Chase & Co. - MarketBeat

Dec 17, 2024

Dec 16, 2024

TransMedics Stock Plunges 57.5% in Three Months: What's Next? - MSN

Dec 16, 2024

TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles - Investing.com Canada

Dec 16, 2024

TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 14, 2024

TMDX stock touches 52-week low at $64.83 amid market shifts By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 13, 2024

TMDX stock touches 52-week low at $64.83 amid market shifts - Investing.com

Dec 13, 2024

TransMedics reports inducement grants under Nasdaq listing rule - Medical Buyer

Dec 13, 2024

Research Analysts Set Expectations for TMDX Q3 Earnings - MarketBeat

Dec 13, 2024

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Kilgore News Herald

Dec 13, 2024

Dec 12, 2024

TransMedics Welcomes New CFO with $1.4M Equity Package; Grants Strategic Inducement Awards - StockTitan

Dec 12, 2024

Q1 EPS Estimate for TransMedics Group Decreased by Analyst - MarketBeat

Dec 12, 2024